Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...
“I’m not opposed to the concept of equity financing, I believe that preserving equity is fundamental to preserving a Founder’s vision,” said Ryan Saadi, Founder and CEO of Tevogen Bio. “From a ...
Founded in Tokyo in the fall of 2022, Quanmatic Inc. develops world-class algorithmic software solutions by utilizing a wide array of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback